Relative risk and attributable riskpsm mbbs

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Searching Images

relative risk attributable risk epidemiology cohort study table

<table><thead><tr><th>Outcome Timeframe</th><th>Study results and measurements</th><th>Comparator No IRS</th><th>Intervention IRS</th><th>Certainty of the evidence (Quality of evidence)</th><th>Summary</th></tr></thead><tbody><tr><td>(children under 5) (nRCT and controlled before-and-after data) follow-up: range 6-12 months</td><td>(Observational (non-randomized))</td><td>IRS. The risk of malaria infection in the sprayed group relative to the unsprayed group was 0.28 (95% CI: 0.10–0.77). Mashauri examined participants for malaria infection six months post-IRS. The risk of malaria infection was 0.19 (95% CI: 0.07–0.48) for those in the sprayed group compared to those in the unsprayed group.</td><td></td><td>risk of bias 6</td><td>of IRS on malaria prevalence in children under 5 years of age compared to no IRS when followed up from six months to 12 months.</td></tr><tr><td>Malaria, point prevalence (children 5-15 years) follow-up: range 3-6 months</td><td>Based on data from 2,752 participants in 2 studies. (Randomized controlled)</td><td>Curtis examined children over 6 years of age approximately three months post-IRS (first quarter of 1996, spraying in December 1995). The risk of malaria infection in the sprayed cohort relative to the unsprayed cohort was 1.10 (95% CI: 0.94–1.29). Rowland examined children between 5 and 15 years of age three months post-IRS. The risk of malaria infection in the sprayed cohort relative to the unsprayed cohort was 0.15 (95% CI: 0.06–0.37).</td><td></td><td>Very low Due to serious risk of bias, Due to serious inconsistency, Due to serious imprecision 7</td><td>The evidence is very uncertain about the effect of IRS on malaria prevalence in children aged 5 to 15 years compared to no IRS when followed up from three months to six months.</td></tr><tr><td>Malaria, point prevalence (children aged 5-15 years) (nRCT and controlled before-and-after data) follow-up: range 6-12 months</td><td>Based on data from 907 participants in 2 studies. (Observational (non-randomized))</td><td>Guyatt tested participants for malaria infection approximately two months after IRS. The risk of malaria infection in the sprayed group relative to the unsprayed group was 0.32 (95% CI: 0.19–0.55). Mashauri examined participants for malaria infection six months post-IRS. The risk of malaria infection was 0.60 (95% CI: 0.42–0.87) for those in the sprayed group compared to those in the unsprayed group.</td><td></td><td>Very low Due to very serious risk of bias, Due to serious imprecision 8</td><td>The evidence is very uncertain about the effect of IRS on malaria prevalence in children aged 5 to 15 years compared to no IRS when followed up from six months to 12 months.</td></tr><tr><td>Malaria, point prevalence (aged 15+ years) (nRCT and controlled before-and-after data) follow-up: range 6-12 months</td><td>Based on data from 916 participants in 2 studies. (Observational (non-randomized))</td><td>Guyatt tested participants for malaria infection approximately two months after IRS. The risk of malaria infection in the unsprayed group relative to the unsprayed group was 0.17 (95% CI: 0.07–0.43). Mashauri examined participants for malaria infection six months post-IRS. The risk of malaria infection was 1.26 (95% CI: 0.57–2.76) for those in the sprayed group compared to those in the unsprayed group.</td><td></td><td>Very low Due to very serious risk of bias, Due to serious imprecision 9</td><td>The evidence is very uncertain about the effect of IRS on malaria prevalence in those aged 15 years or older compared to no IRS when followed up from six months to 12 months.</td></tr><tr><td>Death, incidence rate (children under 5 years) follow-up: mean 3 months</td><td>Based on data from 2,000 participants in 1 studies. (Randomized controlled)</td><td>There were no deaths in children under 5 years in the treated camps within three months following IRS. Confidence intervals could not be estimated.</td><td></td><td>Very low Due to serious risk of bias, Due to serious indirectness, Due to serious imprecision 10</td><td>The evidence is very uncertain about the effect of IRS on all-cause deaths in children under 5 years of age compared to no IRS when followed up for 3 months.</td></tr></tbody></table>

<table><thead><tr><th>Outcome Timeframe</th><th>Study results and measurements</th><th>Comparator No IRS</th><th>Intervention IRS</th><th>Certainty of the evidence (Quality of evidence)</th><th>Summary</th></tr></thead><tbody><tr><td>(children under 5) (nRCT and controlled before-and-after data) follow-up: range 6-12 months</td><td>(Observational (non-randomized))</td><td>IRS. The risk of malaria infection in the sprayed group relative to the unsprayed group was 0.28 (95% CI: 0.10–0.77). Mashauri examined participants for malaria infection six months post-IRS. The risk of malaria infection was 0.19 (95% CI: 0.07–0.48) for those in the sprayed group compared to those in the unsprayed group.</td><td></td><td>risk of bias 6</td><td>of IRS on malaria prevalence in children under 5 years of age compared to no IRS when followed up from six months to 12 months.</td></tr><tr><td>Malaria, point prevalence (children 5-15 years) follow-up: range 3-6 months</td><td>Based on data from 2,752 participants in 2 studies. (Randomized controlled)</td><td>Curtis examined children over 6 years of age approximately three months post-IRS (first quarter of 1996, spraying in December 1995). The risk of malaria infection in the sprayed cohort relative to the unsprayed cohort was 1.10 (95% CI: 0.94–1.29). Rowland examined children between 5 and 15 years of age three months post-IRS. The risk of malaria infection in the sprayed cohort relative to the unsprayed cohort was 0.15 (95% CI: 0.06–0.37).</td><td></td><td>Very low Due to serious risk of bias, Due to serious inconsistency, Due to serious imprecision 7</td><td>The evidence is very uncertain about the effect of IRS on malaria prevalence in children aged 5 to 15 years compared to no IRS when followed up from three months to six months.</td></tr><tr><td>Malaria, point prevalence (children aged 5-15 years) (nRCT and controlled before-and-after data) follow-up: range 6-12 months</td><td>Based on data from 907 participants in 2 studies. (Observational (non-randomized))</td><td>Guyatt tested participants for malaria infection approximately two months after IRS. The risk of malaria infection in the sprayed group relative to the unsprayed group was 0.32 (95% CI: 0.19–0.55). Mashauri examined participants for malaria infection six months post-IRS. The risk of malaria infection was 0.60 (95% CI: 0.42–0.87) for those in the sprayed group compared to those in the unsprayed group.</td><td></td><td>Very low Due to very serious risk of bias, Due to serious imprecision 8</td><td>The evidence is very uncertain about the effect of IRS on malaria prevalence in children aged 5 to 15 years compared to no IRS when followed up from six months to 12 months.</td></tr><tr><td>Malaria, point prevalence (aged 15+ years) (nRCT and controlled before-and-after data) follow-up: range 6-12 months</td><td>Based on data from 916 participants in 2 studies. (Observational (non-randomized))</td><td>Guyatt tested participants for malaria infection approximately two months after IRS. The risk of malaria infection in the unsprayed group relative to the unsprayed group was 0.17 (95% CI: 0.07–0.43). Mashauri examined participants for malaria infection six months post-IRS. The risk of malaria infection was 1.26 (95% CI: 0.57–2.76) for those in the sprayed group compared to those in the unsprayed group.</td><td></td><td>Very low Due to very serious risk of bias, Due to serious imprecision 9</td><td>The evidence is very uncertain about the effect of IRS on malaria prevalence in those aged 15 years or older compared to no IRS when followed up from six months to 12 months.</td></tr><tr><td>Death, incidence rate (children under 5 years) follow-up: mean 3 months</td><td>Based on data from 2,000 participants in 1 studies. (Randomized controlled)</td><td>There were no deaths in children under 5 years in the treated camps within three months following IRS. Confidence intervals could not be estimated.</td><td></td><td>Very low Due to serious risk of bias, Due to serious indirectness, Due to serious imprecision 10</td><td>The evidence is very uncertain about the effect of IRS on all-cause deaths in children under 5 years of age compared to no IRS when followed up for 3 months.</td></tr></tbody></table>

This Comparison Chart consists of three vertically aligned line graphs illustrating the relationship between air quality and human health risk over a study period from March 2015 to April 2017. The top panel displays the Air Quality Index (AQI), with values ranging from 0 to 450. The middle panel shows the Total Relative Risk (RRTotal), a clinical epidemiological measure of health hazard, fluctuating between 1.050 and 1.275. The bottom panel presents the Health-based Air Quality Index (HAQI), scaled from 0 to 840. Visually, all three curves demonstrate high synchronicity, exhibiting marked seasonal fluctuations characterized by peaks in winter months (notably December 2015 and December 2016) and valleys during summer months. The graph serves as a public health visualization tool to demonstrate how air pollution levels (AQI/HAQI) correlate with short-term clinical health risks (RRTotal). This content is relevant to environmental health, respiratory medicine, and medical epidemiology, illustrating the impact of environmental factors on population health outcomes.

This Comparison Chart consists of three vertically aligned line graphs illustrating the relationship between air quality and human health risk over a study period from March 2015 to April 2017. The top panel displays the Air Quality Index (AQI), with values ranging from 0 to 450. The middle panel shows the Total Relative Risk (RRTotal), a clinical epidemiological measure of health hazard, fluctuating between 1.050 and 1.275. The bottom panel presents the Health-based Air Quality Index (HAQI), scaled from 0 to 840. Visually, all three curves demonstrate high synchronicity, exhibiting marked seasonal fluctuations characterized by peaks in winter months (notably December 2015 and December 2016) and valleys during summer months. The graph serves as a public health visualization tool to demonstrate how air pollution levels (AQI/HAQI) correlate with short-term clinical health risks (RRTotal). This content is relevant to environmental health, respiratory medicine, and medical epidemiology, illustrating the impact of environmental factors on population health outcomes.

Evidentiary Table. (continued)
<table><thead><tr><th>Author & Year Published</th><th>Class of Evidence</th><th>Setting & Study Design</th><th>Methods & Outcome Measures</th><th>Results</th><th>Limitations & Comments</th></tr></thead><tbody><tr><td>Kerber et al<sup>82</sup> (2015)</td><td>III for Q4</td><td>Prospective cohort study at 1 center in Michigan; the target population was patients presenting for acute dizziness without an obvious cause who also had examination findings (ie, nystagmus [spontaneous or gaze-evoked] or imbalance when walking) that could be attributable to neurologic dysfunction</td><td>Evaluated the ability of the combination of bedside predictors of stroke—including both the ABCD2 score and the specialized OM examination-to stratify stroke risk using an MRI-based industry standard; study examinations were performed before the MRI whenever possible or blinded to the results of the MRI; OM examination was performed including a nystagmus assessment, assessment of skew deviation, and the head impulse test; primary outcome was an imaging-based definition of stroke, specifically any acute infarction or ICH on MRI as determined by a neuroradiologist</td><td>N=320 patients; stroke rate 11% in multivariable logistic regression models, ABCD2 OR 1.74 (95% CI 1.20 to 2.5); HINTS positive OR 2.82 (95% CI 0.96 to 8.30); false-negative frequency (ie, frequency of stroke in the lowest-risk categories) was as follows: ABCD2 <4, 5.1% (8/157); OM assessment, 5.9% (9/152) (4.9% [4/82], for HINTS peripheral findings); other CNS features, 7.8% (17/219); and prior stroke, 10.8% (28/260); the OM assessment was positive for a central lesion in 20 of the 29 stroke patients (69%); of the 9 stroke patients who did not have the central OM findings, 7 patients were in the no-nystagmus category (5) and/or had an acute infarction that was possibly incidental (3)</td><td>15% did not receive MRI within 14 d; physical examination was performed in a structured fashion by a study investigator, either a neurologist fellowship trained in neuro-otology or vascular neurology, or an emergency medicine physician fellowship trained in vascular neurology—not generalizable to the general EM professional population</td></tr></tbody></table>

Evidentiary Table. (continued) <table><thead><tr><th>Author & Year Published</th><th>Class of Evidence</th><th>Setting & Study Design</th><th>Methods & Outcome Measures</th><th>Results</th><th>Limitations & Comments</th></tr></thead><tbody><tr><td>Kerber et al<sup>82</sup> (2015)</td><td>III for Q4</td><td>Prospective cohort study at 1 center in Michigan; the target population was patients presenting for acute dizziness without an obvious cause who also had examination findings (ie, nystagmus [spontaneous or gaze-evoked] or imbalance when walking) that could be attributable to neurologic dysfunction</td><td>Evaluated the ability of the combination of bedside predictors of stroke—including both the ABCD2 score and the specialized OM examination-to stratify stroke risk using an MRI-based industry standard; study examinations were performed before the MRI whenever possible or blinded to the results of the MRI; OM examination was performed including a nystagmus assessment, assessment of skew deviation, and the head impulse test; primary outcome was an imaging-based definition of stroke, specifically any acute infarction or ICH on MRI as determined by a neuroradiologist</td><td>N=320 patients; stroke rate 11% in multivariable logistic regression models, ABCD2 OR 1.74 (95% CI 1.20 to 2.5); HINTS positive OR 2.82 (95% CI 0.96 to 8.30); false-negative frequency (ie, frequency of stroke in the lowest-risk categories) was as follows: ABCD2 <4, 5.1% (8/157); OM assessment, 5.9% (9/152) (4.9% [4/82], for HINTS peripheral findings); other CNS features, 7.8% (17/219); and prior stroke, 10.8% (28/260); the OM assessment was positive for a central lesion in 20 of the 29 stroke patients (69%); of the 9 stroke patients who did not have the central OM findings, 7 patients were in the no-nystagmus category (5) and/or had an acute infarction that was possibly incidental (3)</td><td>15% did not receive MRI within 14 d; physical examination was performed in a structured fashion by a study investigator, either a neurologist fellowship trained in neuro-otology or vascular neurology, or an emergency medicine physician fellowship trained in vascular neurology—not generalizable to the general EM professional population</td></tr></tbody></table>

Here is a complete, exam-focused explanation of Relative Risk and Attributable Risk for PSM/Community Medicine (MBBS):

Relative Risk and Attributable Risk

(Park's PSM - Cohort Study / Epidemiology)


Context: Where These Measures Come From

In a cohort study, two groups are followed:
  • Exposed group (e.g., smokers)
  • Non-exposed group (e.g., non-smokers)
After follow-up, incidence rates are calculated, and then two key risk estimates are derived: Relative Risk (RR) and Attributable Risk (AR).

1. RELATIVE RISK (RR)

Definition: RR is the ratio of the incidence of disease (or death) among the exposed group to the incidence among the non-exposed group.
$$\text{RR} = \frac{\text{Incidence among exposed}}{\text{Incidence among non-exposed}}$$
Example (smoking and lung cancer):
  • Incidence among smokers = 10/1000
  • Incidence among non-smokers = 1/1000
  • RR = 10/1 = 10
This means smokers are 10 times more likely to develop lung cancer than non-smokers.

Interpretation of RR:

RR ValueMeaning
RR = 1No association
RR > 1Positive association (risk factor)
RR < 1Negative association (protective factor)
RR = 2100% increase in risk among exposed
RR = 0.2575% reduction in risk among exposed
Use of RR: It is the best measure of the strength of association between a suspected cause and its effect. Used in aetiological enquiries - i.e., finding out what causes disease.

2. ATTRIBUTABLE RISK (AR)

Definition: AR is the difference in incidence rates between the exposed and non-exposed groups. Also called "risk difference" or "excess risk".
$$\text{AR} = \text{Incidence (exposed)} - \text{Incidence (non-exposed)}$$

Attributable Risk Percent (AR%):

$$\text{AR%} = \frac{\text{Incidence (exposed)} - \text{Incidence (non-exposed)}}{\text{Incidence (exposed)}} \times 100$$
Example (same data):
$$\text{AR%} = \frac{10 - 1}{10} \times 100 = 90%$$
This means 90% of lung cancer among smokers is attributable to smoking - i.e., could be prevented if smoking were eliminated.
Use of AR: Measures the public health impact of a risk factor. Tells us how much disease could be prevented by removing the exposure.

3. POPULATION ATTRIBUTABLE RISK (PAR)

Definition: PAR = Incidence in the total population minus incidence among non-exposed.
$$\text{PAR} = \text{Incidence (total population)} - \text{Incidence (non-exposed)}$$
Example (UK Physicians Study - Table 19 in Park):
GroupDeaths per 100,000/year
Heavy smokers224
Non-smokers10
Total population74
  • Individual RR = 224/10 = 22.4
  • Population AR = (74 - 10)/74 = 86%
This means 86% of lung cancer deaths in the total population could be prevented by eliminating smoking.

4. RELATIVE RISK vs. ATTRIBUTABLE RISK - Key Distinction

This is a favourite MBBS/exam comparison topic:
FeatureRelative RiskAttributable Risk
DefinitionRatio of incidencesDifference of incidences
PurposeMeasures strength of associationMeasures public health impact
Best used forAetiological research (cause-finding)Preventive/public health programmes
Not affected by baseline prevalenceYesNo - depends on background rate

Classic Example (Oral Contraceptives & CVS Complications - Table 20):

Age GroupRelative RiskAttributable Risk
30-39 years2.83.5 per 100,000
40-44 years2.820.0 per 100,000
  • RR is the same across age groups - same strength of association.
  • AR is 5x higher in older women - far greater absolute burden.
  • This is why OCP use is not recommended in women aged 35+ - the AR (public health impact) is much higher, even though RR is the same.

Second Classic Example (Smoking - Table 21):

Cause of DeathSmokersNon-smokersRRAR%
Lung cancer0.90/10000.07/100012.8692.2%
Coronary Heart Disease4.87/10004.22/10001.1513.3%
  • Smoking has a very high RR for lung cancer (strong causal link).
  • But for CHD, both RR and AR are low - smoking doesn't explain much of the CHD burden.

5. QUICK MEMORY AID

  • RR = Ratio → tells you "How strong is the link?" → used in aetiology
  • AR = Difference → tells you "How much disease can be prevented?" → used in public health
  • PAR = same idea but for the whole population

Summary Formula Box (Exam Ready)

$$\boxed{\text{RR} = \frac{I_e}{I_{\bar{e}}}}$$
$$\boxed{\text{AR%} = \frac{I_e - I_{\bar{e}}}{I_e} \times 100}$$
$$\boxed{\text{PAR} = I_{total} - I_{\bar{e}}}$$
Where $I_e$ = incidence in exposed, $I_{\bar{e}}$ = incidence in non-exposed.

Source: Park's Textbook of Preventive and Social Medicine, Chapter on Cohort Studies, pp. 90-91

Blindness programe psm mbbs

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Here is a complete, exam-ready PSM/Community Medicine note on the Blindness Control Programme:

National Programme for Control of Blindness (NPCB)

PSM - MBBS | Park's Textbook


DEFINITIONS

Blindness (Old definition - India, adopted 1976): Visual acuity less than 3/60 (unable to count fingers at 6 metres) in the better eye with best correction.
Blindness (New WHO-aligned definition - India, revised ~2018): A person who is unable to count fingers from a distance of 3 metres - this revised definition brought India in line with WHO criteria. Under this new definition, the blind population in India reduced from 1.20 crore to 80 lakh.
Visual Impairment: Visual acuity < 6/18 in the better eye.

MAGNITUDE OF BLINDNESS IN INDIA

SurveyPrevalence of Blindness
1976 (at programme launch)1.4%
Rapid National Survey (2006-07)1.0%
Current National Survey (2015-19)0.36%
Programme Goal: Reduce prevalence from 1.4% to 0.3% - this goal has now nearly been achieved.

CAUSES OF BLINDNESS IN INDIA

(National Survey on Blindness 2015-19)

CausePercentage
Cataract (untreated)66.2% - LEADING CAUSE
Cataract surgical complications7.2%
Non-trachomatous corneal opacity7.4%
Other posterior segment disease5.9%
Glaucoma5.5%
Aphakia uncorrected1.7%
Diabetic retinopathy1.2%
Phthisis2.8%
Trachomatous corneal opacity0.8%
ARMD0.7%
Refractive error0.1%
Exam point: Cataract is the single most important cause of blindness in India (~66%). It occurs a decade earlier in India compared to Europe/America. Avoidable blindness (preventable + curable) accounts for the vast majority of cases.

EPIDEMIOLOGICAL DETERMINANTS

FactorDetails
Age~30% lose sight before age 20; Vit A deficiency, trachoma in children; cataract, glaucoma in elderly
SexHigher prevalence in females (more trachoma, conjunctivitis, cataract)
MalnutritionVitamin A deficiency → xerophthalmia, keratomalacia (especially 6 months - 3 years of age)
OccupationFactory/workshop workers - dust, radiation (UV, X-ray), welding flash → eye injuries, premature cataracts
Social classBlindness twice as prevalent in poorer classes
Social factorsQuacks (meddlesome ophthalmology), ignorance, poverty, poor hygiene

NATIONAL PROGRAMME FOR CONTROL OF BLINDNESS (NPCB)

Launch & History

  • Launched: 1976 as a 100% centrally sponsored programme
  • Incorporated: Earlier Trachoma Control Programme (started 1968, merged 1976)
  • Renamed: "National Programme for Control of Blindness and Visual Impairment" (NPCB-VI)

Objectives (12th Five Year Plan)

  1. Continue 3 "signature activities":
    • Perform 66 lakh cataract operations/year
    • School eye screening + distribute 9 lakh free spectacles/year to children with refractive errors
    • Collect 50,000 donated eyes/year for keratoplasty
  2. Reduce backlog of avoidable blindness by treatment at primary, secondary, tertiary levels
  3. Develop "Eye Health for All" strategy - comprehensive universal eye care
  4. Strengthen Regional Institutes of Ophthalmology (RIOs) as centres of excellence
  5. Develop human resources for quality eye care in all districts
  6. Enhance community awareness and preventive measures
  7. Expand research in blindness prevention
  8. Involve voluntary organisations and private practitioners

STRATEGIES / SALIENT FEATURES

  1. Free cataract surgery through health system + NGOs + private practitioners
  2. Comprehensive eye care beyond cataract - diabetic retinopathy, glaucoma, corneal transplantation, childhood blindness
  3. Active screening of population above 50 years - organize eye camps, transport operable cases
  4. Refractive error screening in school children - free spectacles for poor
  5. Public-private partnership for underserved areas
  6. Capacity building of health personnel
  7. IEC (Information, Education, Communication) for community awareness
  8. Strengthen Regional Institutes of Ophthalmology and Medical Colleges
  9. Strengthen district hospitals - infra, equipment, ophthalmologists, PMOAs
  10. Vision Centres in all PHCs with Para-Medical Ophthalmic Assistants (PMOAs)
  11. Multipurpose District Mobile Ophthalmic Units for better rural coverage

ADMINISTRATIVE STRUCTURE

LevelBody
CentralOphthalmology Section, DGHS, Ministry of Health & Family Welfare, New Delhi
StateState Ophthalmic Cell / State Health Societies
DistrictDistrict Blindness Control Society (merged with District Health Society under NRHM)

SERVICE DELIVERY & REFERRAL SYSTEM

LevelFacility
TertiaryRegional Institutes of Ophthalmology, Centres of Excellence, Medical Colleges
SecondaryDistrict Hospitals, NGO Eye Hospitals
PrimarySub-district hospitals, CHCs, Mobile Ophthalmic Units, Upgraded PHCs
  • 80 central mobile units attached to medical colleges
  • 341 district mobile units for eye camps in rural areas

METHODS OF INTERVENTION (Prevention of Blindness)

(a) Primary Eye Care

  • Village health guides, MPWs trained to treat: acute conjunctivitis, ophthalmia neonatorum, trachoma, superficial foreign bodies, xerophthalmia
  • Given essential drugs: topical tetracycline, Vitamin A capsules, eye bandages
  • Refer difficult cases to PHC/district hospital
  • Based on primary health care principles (Alma Ata Declaration, 1978)

(b) Secondary Care

  • Definitive management: cataract, trichiasis, entropion, ocular trauma, glaucoma
  • Provided at PHCs and district hospitals
  • Eye camp approach - highly successful for cataract in rural India

(c) Tertiary Care

  • National/regional capitals, Medical Colleges
  • Retinal detachment surgery, corneal grafting, complex management
  • National Institute for the Blind - Dehradun (rehabilitation)

(d) Specific Programmes

  • Trachoma Control - mass campaigns with topical tetracycline (merged with NPCB 1976)
  • School Eye Health Services - screening for refractive errors, squint, amblyopia
  • Vitamin A prophylaxis - prevention of nutritional blindness

SCHOOL EYE SCREENING PROGRAMME

  • 6-7% of children aged 10-14 years have eye problems affecting learning
  • First screened by trained teachers
  • Suspected refractive error cases seen by ophthalmic assistants
  • Free spectacles given to children below poverty line

EYE DONATION PROGRAMME

  • Eye Donation Fortnight: 25th August to 8th September every year
  • Hospital retrieval programme - motivate relatives of terminally ill/accident victims
  • During 2018-19: 68,409 donated eyes collected for corneal implantation
  • Leading states: Gujarat, Tamil Nadu, Maharashtra, Andhra Pradesh
  • NGOs involved: Lions International, Rotary International, NSPB India

VISION 2020: THE RIGHT TO SIGHT

  • Global initiative to eliminate avoidable blindness by year 2020
  • India is a committed partner
Target diseases: Cataract, Refractive errors, Childhood blindness, Corneal blindness, Glaucoma, Diabetic retinopathy
Four-tier structure (proposed):
TierNumber
Centres of Excellence20
Training Centres200
Service Centres2,000
Vision Centres20,000

CHANGING CONCEPTS IN EYE HEALTH CARE

  1. Primary eye care - eye care component integrated into PHC system
  2. Epidemiological approach - population-level studies; local situation determines action
  3. Team concept - use of auxiliary health personnel (ophthalmic assistants, MPWs, village health workers) due to shortage of specialists
  4. National programmes - comprehensive programme replacing single-disease campaigns

QUICK EXAM SUMMARY

FactValue
NPCB launched1976
Programme type100% centrally sponsored
Leading cause of blindness in IndiaCataract (66.2%)
Original targetReduce prevalence from 1.4% to 0.3%
Current prevalence (2015-19)0.36%
Old definition of blindness (India)<3/60 at 6 metres
New definition (WHO-aligned)Cannot count fingers at 3 metres
Eye donation fortnight25 Aug - 8 Sep
Vision CentresIn all PHCs, with PMOA
Trachoma programme merged1976 (started 1968)

Source: Park's Textbook of Preventive and Social Medicine, Chapter on National Health Programmes & Ophthalmology, pp. 453-454, 497-498
This is a shared conversation. Sign in to Orris to start your own chat.